Pulmonx Return on Tangible Equity 2019-2023 | LUNG
Current and historical return on tangible equity values for Pulmonx (LUNG) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Pulmonx Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $-0.06B | $0.12B | -47.66% |
| 2023-09-30 | $-0.06B | $0.12B | -44.53% |
| 2023-06-30 | $-0.06B | $0.13B | -40.96% |
| 2023-03-31 | $-0.06B | $0.14B | -37.82% |
| 2022-12-31 | $-0.06B | $0.15B | -35.60% |
| 2022-09-30 | $-0.06B | $0.16B | -33.05% |
| 2022-06-30 | $-0.05B | $0.17B | -29.15% |
| 2022-03-31 | $-0.05B | $0.18B | -26.74% |
| 2021-12-31 | $-0.05B | $0.19B | -24.14% |
| 2021-09-30 | $-0.05B | $0.20B | -21.33% |
| 2021-06-30 | $-0.04B | $0.21B | -35.94% |
| 2021-03-31 | $-0.04B | $0.21B | -66.96% |
| 2020-12-31 | $-0.03B | $0.22B | -984.62% |
| 2020-06-30 | $-0.02B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.370B | $0.069B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.170B | 20.41 |
| Inspire Medical Systems (INSP) | United States | $7.442B | 0.00 |
| Axonics (AXNX) | United States | $3.438B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.304B | 0.00 |
| 10x Genomics (TXG) | United States | $3.115B | 0.00 |
| Azenta (AZTA) | United States | $3.074B | 250.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.887B | 0.00 |
| Enovis (ENOV) | United States | $2.865B | 21.24 |
| Hims & Hers Health (HIMS) | United States | $2.646B | 0.00 |
| Privia Health (PRVA) | United States | $2.284B | 101.32 |
| Schrodinger (SDGR) | United States | $1.715B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.10 |
| Phreesia (PHR) | United States | $1.274B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.854B | 0.00 |
| Standard BioTools (LAB) | United States | $0.688B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.638B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.400B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.225B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.210B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.161B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.09 |
| 111 (YI) | China | $0.098B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.067B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| ETAO (ETAO) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |